For routine maintenance, cells were grown in Dulbecco's modification of Eagle's medium (DME) supplemented with 5% fetal bovine serum (FBS; PAA Labor und Forschungs Ges, MBH, Linz, Austria) in an atmosphere of 5% C02/95% air under saturating humidity at 37°C, except for MCF7 cells BB104, which were routinely maintained in 10% charcoal dextran-treated human serum (CDHS)-supplemented phenol red-free DME medium, prepared as described below.
The use of pesticides in agriculture and the release of chemical compounds from manufacturing industries are common in southern Europe. Evidence of the estrogenic effects of some pesticides (1), alkylphenols (2) , and plastic monomers (3) has raised concerns about environmental contamination by these chemicals. We became interested in the use of an estrogenicity test to assess the environmental and human health effects of estrogenic xenobiotics and to discriminate between estrogenic and nonestrogenic chemicals. Tests based on increased mitotic activity in tissues of the genital tract of female rodents after administration of chemicals have been proposed (4); but, although reliable, these methods are not suitable for large-scale screening of suspected estrogenic chemicals or for measuring the total estrogenic burden in human samples. We therefore adopted the biologically equivalent, easily performed E-screen assay described by Soto et al. (5) . This bioassay compares the cell yield between cultures of breast tumor-derived MCF7 cells treated with estradiol and cultures treated with different concentrations of xenobiotics suspected of being estrogenic. MCF7 cells were recommended as target cells because of their widely acknowledged estrogen-sensitivity (6) .This cell line was initially established by Soule et (8) .
The purpose of this study was to characterize the response of four MCF7 cell stocks routinely held by different laboratories to assess which of them performs best in the E-screen test. We investigated the proliferative pattern and rate of estrogeninduced synthesis of cell type-specific proteins and the effects ofp-nonyl-phenol and bisphenol-A on the four cell stocks. For routine maintenance, cells were grown in Dulbecco's modification of Eagle's medium (DME) supplemented with 5% fetal bovine serum (FBS; PAA Labor und Forschungs Ges, MBH, Linz, Austria) in an atmosphere of 5% C02/95% air under saturating humidity at 37°C, except for MCF7 cells BB104, which were routinely maintained in 10% charcoal dextran-treated human serum (CDHS)-supplemented phenol red-free DME medium, prepared as described below.
Methods
Plasma-derived human serum was prepared from expired plasma by adding calcium chloride to a final concentration of 30 mM to facilitate clot formation. Sex steroids were removed from serum by charcoal-dextran stripping (6) .
Cellproliferation experiments. We used MCF7 cells in the E-screen test according to a technique slightly modified from that originally described by Soto et al. (5) . Briefly, cells were trypsinized and plated in 24-well plates (Limbro, McLean, Virginia) at an initial concentration of 10,000 cells per well in 5% FBS in DME. BB104 cells were seeded in 10% CDHS supplemented medium. The cells were allowed to attach for 24 hr, then 10% CDHS-supplemented phenol red-free DME was substituted for the seeding medium. A range of concentrations of the test compound were added, and the assay was stopped after 144 hr by removing the medium from wells, fixing the cells, and staining them with sulforhodamine-B (SRB).
The fixation and staining technique was modified from that described by Skehan et al. (9) . Briefly, cells were treated with cold 10% trichloracetic acid and incubated at 4°C for 30 (6) .
We used the E-screen test to determine, for all four MCF7 cell stocks, the relative proliferative potency (RPP), defined as the ratio between the minimum concentration of estradiol-17f7 needed for maximal cell yield and the minimum dose of the test compound needed to obtain a similar effect, and the relative proliferative effect (RPE) ; that is, the ratio between the highest cell yield obtained with the chemical and with estradiol-17f3 x 100 (5) .
Results are expressed as the means plus or minus standard deviations. In proliferation yield experiments, each point is the mean of three counts from four culture wells. Mean cell numbers were normalized to the steroid-free control, equal to 1, to correct for differences in the initial plating density. Differences between the diverse groups were calculated with Student's S-test.
Estrogen andprogesterone receptor measurements. We seeded MCF7 cells in T-25 flasks in 5% FBS-supplemented DME. The next day, the medium was changed to 10% CDHS-supplemented DME medium, and estradiol-17l3 or the chemicals to be tested were added. One group of cells received vehicle alone. After 72 hr, the culture medium was discarded and cells were frozen in liquid nitrogen. To extract receptor molecules, cells were incubated at 40C for 30 min with 1 mL of extraction buffer (0.5M KCI, 10 mM potassium phosphate, 1.5 mM EDTA, and 1 mM monothioglycerol, pH 7.4) according to a previously described technique (10) . The cell debris were pelleted, and estrogen receptors and progesterone receptors were measured in a 100-1tL extract aliquot by enzyme immunoassay using the Abbott estrogen receptor and progesterone receptor-enzyme immunoassay monoclonal kits (Abbott Diagnostic, Wiesbaden, Germany) according to the manufacturer's instructions.
Cell type-specific proteins and compounds tested. Cathepsin-D and pS2 proteins were measured in culture media with the ELSA-CATH-D and ELSA-pS2 immunoradiometric assays (CIS Biolnter- Articles -E-screen bioassay cell yields in all MCF7 stocks. In MCF7 BUS cells, the proliferative effect was greatest with .0.01 nM estradiol-17B (Fig. 2) Table 2 .
We also studied the response of MCF7 cells to estradiol-17g in medium supplemented with different amounts of serum. MCF7 BUS and BB104 cells were cultured in DME medium with 5-50% CDHS. Figure 3 shows the effect of 0.1 nM estradiol-17g on cell yield. In MCF7 BB104 cells; estradiol-17B consistently increased proliferation (approximately twofold over control values), regardless of the concentration of CD serum added. In MCF7 BUS cells, differences in cell yield between estradiol-17g-treated and nontreated cells decreased as the concentration of serum increased. The effect of 0.1 nM estradiol-17B was maximal when 10% serum was added to the medium. At 50% of serum replacement, 0.1 nM estradiol-17f3 had no apparent effect on MCF7 BUS cells.
Cathepsin-D and pS2 Secretion
Cathepsin-D and pS2 protein accumulation in the culture medium reflected increases in cell number (Fig. 4) (Fig. 4A) . Differences in cathepsin-D protein secretion between the four MCF7 cell stocks were smaller; basal levels ranged from 8.9 ± 4.0 pmol/106 cells in the BUS stock to 19.5 ± 7.8 pmol/106 cells in the BB104 clone. Estradiol-17B treatment slightly increased cathepsin-D accumulation in the culture medium. The greatest effect was seen in BB cells, in which 1 nM estradiol-17f3 raised cathepsin-D protein levels 1.8-fold (Fig. 4B) . (Fig. 5) . Basal levels of progesterone receptor were 24 ± 7, 75 ± 12, and 83 ± 7 fmol/mg of protein in BB104, BB, and ATCC cells, respectively. In all the three stocks, estradiol-17f3 increased progesterone receptor levels in a dose-dependent manner; however, the effect was smaller than that observed in BUS cells (Fig. 5) .
We did another set of experiments to investigate the effect of estrogens on the "disappearance" of estrogen receptors (Table 3 ). In cells treated for 72 hr, estradiol-17I3 significantly increased progesterone receptor and decreased estrogen receptor concentrations. When MCF7 BUS cells were treated with concentrations of >100 nM NP there was a significant increase in progesterone receptor (Table 3) . Treatment with BPA also increased progesterone receptor, but the effect was weaker at higher concentrations (>1000 nM). However, estrogen receptor levels were unchanged when the medium contained NP or BPA.
Discussion
A bioassay can be effectively assessed only with the help of a standardized set of parameters that measure reproducibility. In evaluations of the E-screen test, uniformity of the MCF7 cell stock used is the most important variable that affects reproducibility.
The four MCF7 cell stocks we assayed were distinguishable on the basis of their biological behavior. In the absence of estrogen, MCF7 BUS cells stopped proliferating; they accumulated in the GO/GI phase, estrogen receptor receptor levels increased, progesterone receptor decreased, and low levels of pS2 protein were secreted. Of the MCF7 stocks we tested, MCF7 BUS cells showed the highest proliferative response to estradiol-17f, with cell yields increasing up to sixfold over nontreated cells in a 144-hr period. This increase was of the same order of magnitude as that described previously in monolayer cultures of MCF7 cells (5, (12) (13) (14) (15) (16) .The other three cell stocks responded to estradiol-17f with a much smaller increase in cell yield, which was never higher than twofold over control values. Similar proliferative responses were reported in MCF7 cell stocks tested in media supplemented with different amounts of charcoal dextran serum, which ranged from 20% to 0.5% (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) , and in serumless medium (31) (32) (33) . Poor proliferative responses to estradiol-17t3 were described when nonstripped, serum-supplemented media were used (34) (35) (36) .
Differences in culture condition (29) (30) (31) (32) (33) (34) (35) (36) (37) , the type of serum-supplemented medium (17, 18) , serum lots (17) , the presence of phenol red (38) , insulin (27, 39, 40) , cell passage (41) , and cell density or culture matrices (20, 33, 41) , may explain the poor proliferative effect of estradiol-1711 in some MCF7 cell stocks. The disparate effects of estradiol-17f1, other so-called mitogens, and growth inhibitors on cell proliferation have also been attributed to heterogeneity of the undoned cells (39, 42, 43) or to differences in the MCF7 cells used (8, 13, 16, 25, 44, 45) . The four cell stocks we assayed were cultured in the same medium (phenol red-free DME), which was suppleVolume 103, Number 9, September 1995 * Environmental Health Perspectives
Articles -E-screen bioassa The minimal effect of estradiol-17g on MCF7 ATCC cell yields was notable; similar results have been described by others (30, 32, 35) . Because ATCC cells are from a different patient than the one from which MCF7 cells originated (8) , this stock should be used with caution in cell proliferation tests such as the E-screen bioassay.
Estradiol-17g affected MCF7 BUS cell yield, cell cycle distribution, and specific protein synthesis. In this stock, the hormone reduced estrogen receptor content, increased the amount of measurable progesterone receptor, and increased pS2 protein secretion. We found no significant effect of estradiol-179 on cathepsin-D protein synthesis (25) . Although some MCF7 cell stocks respond to estradiol-17f3 with a higher increase in cathepsin-D protein secretion than others (46) , all four MCF7 cell stocks tested here showed the same poor response. In MCF7 BUS cells, the presence of estradiol-17g in the culture medium had a net stimulatory effect on pS2 protein production, mainly because of the low amounts of this protein secreted in estrogen free-medium.
p-Nonyl-phenol and BPA were found to be estrogenic, increasing cell yield and progesterone receptor concentration in MCF7 cells (2, 3, 47) . These compounds mimicked the proliferative effect of estradiol-179 and increased progesterone receptor levels, albeit to a lower extent than did the hormone. However, the effects of estradiol17f3 and these chemicals on the disappearance of estrogen receptor differed. An increase in progesterone receptor levels was not associated with estrogen receptor downregulation. Interestingly, Schutze et al. (19) showed that catecholestrogens, which increase the rate of MCF7 cell proliferation and progesterone receptor levels, evoked estrogen receptor processing only during the first 8 hr after treatment; thereafter, estrogen receptor increased, reaching basal levels at 24 hr. We are now investigating whether differences in the ability to evoke processing are due to an early phenomenon occurring before 72 hr, when estrogen receptor was routinely evaluated, or whether these differences are related to the use of exchange assays or the immunological detection of estrogen receptor (48) .
Validation of the RPE and RPP of the chemicals tested here seems to depend on the cell stocks used in the E-screen bioassay. Although RPE 
